RET-Altered Cancers—A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 43 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute/National Institutes of Health
Grant: R01CA251591
National Cancer Institute/National Institutes of Health
Grant: R01CA273224-01
National Cancer Institute/National Institutes of Health
Grant: P30CA008748
NCI NIH HHS
Grant: R01 CA273224
National Institutes of Health
Grant: 5R01CA251591-02
Predicting sensitivity and resistance in RET-driven cancers
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01CA273224-03
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy
FWCI
7.24
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals